We are live on ! Find out more
ACM

Ashford Capital Management Portfolio holdings

AUM $809M
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+36.43%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.08%
AUM
$1.03B
AUM Growth
+$192M
Cap. Flow
-$33M
Cap. Flow %
-3.19%
Top 10 Hldgs %
36.3%
Holding
117
New
20
Increased
34
Reduced
38
Closed
8

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$24.7M
2
HRMY icon
Harmony Biosciences
HRMY
+$11M
3
YMAB
Y-mAbs Therapeutics
YMAB
+$10.1M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$8.7M
5
INCY icon
Incyte
INCY
+$8.14M

Top Sells

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$30.9M
2
APPN icon
Appian
APPN
+$25M
3
FVRR icon
Fiverr
FVRR
+$24.7M
4
GLUU
Glu Mobile Inc.
GLUU
+$13.7M
5
TTD icon
Trade Desk
TTD
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 24.43%
2 Industrials 18.1%
3 Healthcare 17.44%
4 Communication Services 11.86%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWD icon
76
Woodward
WWD
$21.4B
$931K 0.09%
7,657
+156
+2% +$15.8K
MORN icon
77
Morningstar
MORN
$7.53B
$905K 0.09%
3,908
+89
+2% +$17.7K
XOM icon
78
ExxonMobil
XOM
$634B
$870K 0.08%
21,109
-8,662
-29% -$325K
GEN icon
79
Gen Digital
GEN
$17.5B
$797K 0.08%
38,334
-27,062
-41% -$546K
BCPC
80
Balchem Corp
BCPC
$5.72B
$760K 0.07%
6,600
– –
IWF icon
81
iShares Russell 1000 Growth ETF
IWF
$128B
$715K 0.07%
+11,860
New +$675K
TECH icon
82
Bio-Techne
TECH
$11.3B
$696K 0.07%
8,764
+240
+3% +$17.4K
MELI icon
83
Mercado Libre
MELI
$92.3B
$670K 0.06%
400
– –
BRO icon
84
Brown & Brown
BRO
$23.9B
$664K 0.06%
14,000
– –
CMD
85
DELISTED
Cantel Medical Corporation
CMD
$645K 0.06%
+8,180
New +$480K
KMI icon
86
Kinder Morgan
KMI
$68.7B
$581K 0.06%
42,502
-34,945
-45% -$468K
BALY icon
87
Bally's
BALY
$658M
$553K 0.05%
+11,000
New +$386K
GGN
88
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$819M
$544K 0.05%
155,000
-67,406
-30% -$233K
LGND icon
89
Ligand Pharmaceuticals
LGND
$6.36B
$521K 0.05%
8,400
– –
BX icon
90
Blackstone
BX
$110B
$506K 0.05%
7,800
– –
IJR icon
91
iShares Core S&P Small-Cap ETF
IJR
$112B
$441K 0.04%
+4,798
New +$394K
VEU icon
92
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$411K 0.04%
+7,042
New +$384K
MRK icon
93
Merck
MRK
$318B
$393K 0.04%
5,030
+314
+7% +$24K
MXIM
94
DELISTED
Maxim Integrated Products
MXIM
$355K 0.03%
4,000
– –
CSIQ icon
95
Canadian Solar
CSIQ
$1.08B
$348K 0.03%
+6,800
New +$279K
JNJ icon
96
Johnson & Johnson
JNJ
$625B
$346K 0.03%
2,200
– –
MDY icon
97
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$311K 0.03%
+740
New +$285K
KC
98
Kingsoft Cloud Holdings
KC
$3.69B
$305K 0.03%
+7,000
New +$259K
TROW icon
99
T. Rowe Price
TROW
$24.3B
$297K 0.03%
1,959
– –
GLW icon
100
Corning
GLW
$143B
$293K 0.03%
8,136
– –
1 2 3
4
5

Similar funds

RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return
AF
Ally Financial Detroit, Michigan $804M AUM 0.18% 1-Year Est. Return

Ashford Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Ashford Capital Management held 117 positions worth $1.03B, up 23% from $841M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Ashford Capital Management withdrew a net $33M in Q4 2020, closing 8 positions and reducing 38 holdings. Its most notable exit was Livongo Health, Inc. Common Stock, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Ashford Capital Management opened a new position in Teladoc Health worth $24.3M.

  • Ashford Capital Management's largest Q4 2020 buy was Teladoc Health: 121,567 shares worth $24.3M.
  • Ashford Capital Management added most to Supernus Pharmaceuticals in Q4 2020, an estimated $8.7M increase.
  • Ashford Capital Management's biggest Q4 2020 reduction was Appian, cutting an estimated $25M.
  • Ashford Capital Management fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $30.9M.
  • Ashford Capital Management's ten largest holdings make up 36% of its $1.03B portfolio in Q4 2020.
  • Ashford Capital Management opened 20 new positions and closed 8 in Q4 2020.
  • Ashford Capital Management's portfolio value rose 23% quarter-over-quarter to $1.03B.

Based on Ashford Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.